278 related articles for article (PubMed ID: 25458540)
21. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
Bermudez M; Wolber G
Bioorg Med Chem; 2015 Jul; 23(14):3907-12. PubMed ID: 25828056
[TBL] [Abstract][Full Text] [Related]
22. Comparing Class A GPCRs to bitter taste receptors: Structural motifs, ligand interactions and agonist-to-antagonist ratios.
Di Pizio A; Levit A; Slutzki M; Behrens M; Karaman R; Niv MY
Methods Cell Biol; 2016; 132():401-27. PubMed ID: 26928553
[TBL] [Abstract][Full Text] [Related]
23. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
Bhattacharya S; Hall SE; Vaidehi N
J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
[TBL] [Abstract][Full Text] [Related]
24. The use of GPCR structures in drug design.
Congreve M; Langmead C; Marshall FH
Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
[TBL] [Abstract][Full Text] [Related]
25. Advances in Computational Techniques to Study GPCR-Ligand Recognition.
Ciancetta A; Sabbadin D; Federico S; Spalluto G; Moro S
Trends Pharmacol Sci; 2015 Dec; 36(12):878-890. PubMed ID: 26538318
[TBL] [Abstract][Full Text] [Related]
26. Strategies to discover unexpected targets for drugs active at G protein-coupled receptors.
Allen JA; Roth BL
Annu Rev Pharmacol Toxicol; 2011; 51():117-44. PubMed ID: 20868273
[TBL] [Abstract][Full Text] [Related]
27. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Ligand Binding to GPCRs Through Computational Methods.
Vasile S; Esguerra M; Jespers W; Oliveira A; Sallander J; Åqvist J; Gutiérrez-de-Terán H
Methods Mol Biol; 2018; 1705():23-44. PubMed ID: 29188557
[TBL] [Abstract][Full Text] [Related]
29. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity.
Moro S; Deflorian F; Bacilieri M; Spalluto G
Curr Pharm Des; 2006; 12(17):2175-85. PubMed ID: 16796562
[TBL] [Abstract][Full Text] [Related]
30. Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
Li YY; Hou TJ; Goddard WA
Curr Med Chem; 2010; 17(12):1167-80. PubMed ID: 20158474
[TBL] [Abstract][Full Text] [Related]
31. Identifying multiple active conformations in the G protein-coupled receptor activation landscape using computational methods.
Dong SS; Goddard WA; Abrol R
Methods Cell Biol; 2017; 142():173-186. PubMed ID: 28964335
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
Kristiansen K
Pharmacol Ther; 2004 Jul; 103(1):21-80. PubMed ID: 15251227
[TBL] [Abstract][Full Text] [Related]
33. New insights from structural biology into the druggability of G protein-coupled receptors.
Mason JS; Bortolato A; Congreve M; Marshall FH
Trends Pharmacol Sci; 2012 May; 33(5):249-60. PubMed ID: 22465153
[TBL] [Abstract][Full Text] [Related]
34. GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects.
Klabunde T; Evers A
Chembiochem; 2005 May; 6(5):876-89. PubMed ID: 15791686
[TBL] [Abstract][Full Text] [Related]
35. John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
Jacobson KA; Gao ZG; Paoletta S; Kiselev E; Chakraborty S; Jayasekara PS; Balasubramanian R; Tosh DK
Comput Struct Biotechnol J; 2015; 13():286-98. PubMed ID: 25973142
[TBL] [Abstract][Full Text] [Related]
36. Predicting GPCR promiscuity using binding site features.
Levit A; Beuming T; Krilov G; Sherman W; Niv MY
J Chem Inf Model; 2014 Jan; 54(1):184-94. PubMed ID: 24328091
[TBL] [Abstract][Full Text] [Related]
37. Recent advances in the determination of G protein-coupled receptor structures.
Thal DM; Vuckovic Z; Draper-Joyce CJ; Liang YL; Glukhova A; Christopoulos A; Sexton PM
Curr Opin Struct Biol; 2018 Aug; 51():28-34. PubMed ID: 29547818
[TBL] [Abstract][Full Text] [Related]
38. What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?
Michino M; Beuming T; Donthamsetti P; Newman AH; Javitch JA; Shi L
Pharmacol Rev; 2015; 67(1):198-213. PubMed ID: 25527701
[TBL] [Abstract][Full Text] [Related]
39. Prediction of structure of G-protein coupled receptors and of bound ligands, with applications for drug design.
Li Y; Goddard WA
Pac Symp Biocomput; 2008; ():344-53. PubMed ID: 18229698
[TBL] [Abstract][Full Text] [Related]
40. Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design.
Vaidehi N
Drug Discov Today; 2010 Nov; 15(21-22):951-7. PubMed ID: 20831898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
